The current state of digital pathology, molecular diagnostics and biobanking in renal cancer: Kidney Cancer Association Consensus Statement

Blackmur, James; Jones, James; Laird, Alexander; Warren, Anne; Leibovich, Bradley; George, Daniel; La Rosa, Salvatore; Pickering, Lisa; Stewart, Grant

Home > Proceedings in Oncology > Proceedings of the 2024 IKCS: Europe Symposium

Read the full Report (pdf)

The 2024 International Kidney Cancer Symposium: Europe 18-20 April, 2024 Sitges, Spain

The current state of digital pathology, molecular diagnostics and biobanking in renal cancer: Kidney Cancer Association Consensus Statement

Conference

IKCS-EU 2024

Author(s)

Blackmur et al.

Type

Proceedings article

17 October 2024 15:36

Influence of immunotherapy combinations on outcomes in sarcomatoid metastatic renal cell carcinoma: results from the UK Renal Oncology Collaborative

Conference

IKCS-EU 2024

Author(s)

Roy et al.

Type

Proceedings article

17 October 2024 15:35

Online First

The current state of digital pathology, molecular diagnostics and biobanking in renal cancer: Kidney Cancer Association Consensus Statement

Conference

IKCS-EU 2024

Author(s)

Blackmur et al.

Type

Proceedings article

17 October 2024 15:36

Influence of immunotherapy combinations on outcomes in sarcomatoid metastatic renal cell carcinoma: results from the UK Renal Oncology Collaborative

Conference

IKCS-EU 2024

Author(s)

Roy et al.

Type

Proceedings article

17 October 2024 15:35

Real-world experience of adjuvant pembrolizumab in resected renal cancer

Conference

IKCS-EU 2024

Author(s)

James et al.

Type

Proceedings article

17 October 2024 15:30

Evaluation of bone response in metastatic renal cell carcinoma treated in first-line with immunotherapy-based combinations

Conference

IKCS-EU 2024

Author(s)

Moinard-Butot et al.

Type

Proceedings article

17 October 2024 15:26

Fumarate hydratase-deficient renal cell carcinoma

Conference

IKCS-EU 2024

Author(s)

Ürün

Type

Proceedings article

17 October 2024 15:25

Treatment of residual RCC following first-line systemic therapy

Conference

IKCS-EU 2024

Author(s)

Ürün

Type

Proceedings article

17 October 2024 15:22

Medical Conferences

Proceedings of the 2024 IKCS: Europe Symposium

Featured articles

The current state of digital pathology, molecular diagnostics and biobanking in renal cancer: Kidney Cancer Association Consensus Statement

Influence of immunotherapy combinations on outcomes in sarcomatoid metastatic renal cell carcinoma: results from the UK Renal Oncology Collaborative

CONTENTS

Online First

The current state of digital pathology, molecular diagnostics and biobanking in renal cancer: Kidney Cancer Association Consensus Statement

Influence of immunotherapy combinations on outcomes in sarcomatoid metastatic renal cell carcinoma: results from the UK Renal Oncology Collaborative

Real-world experience of adjuvant pembrolizumab in resected renal cancer

Evaluation of bone response in metastatic renal cell carcinoma treated in first-line with immunotherapy-based combinations

Fumarate hydratase-deficient renal cell carcinoma

Treatment of residual RCC following first-line systemic therapy